*ST Dayao (603963.SH) announced on January 9 that according to the disclosed "2024 Annual Performance Pre-loss Announcement", the company expects that the total profit, Net income, and Net income after deducting non-recurring gains and losses for the year 2024 will all be negative. Additionally, the revenue after deducting business income unrelated to the main Business and income lacking commercial substance will be less than 0.3 billion yuan. After the disclosure of the 2024 annual report, the company’s Stocks may be delisted by the Shanghai Exchange.
*ST大药(603963.SH)：公司股票可能被终止上市
*Special Treat Pharmaceutical (603963.SH): The company's Stocks may be delisted.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha